Your Stage

Yes. Groupe PARIMA supports programs from early development through GMP manufacturing with capabilities aligned to the stage of the product. Working with one partner across multiple phases can help preserve process knowledge, reduce handoff risk and costs, and simplify coordination as requirements evolve.

As a product progresses, expectations around documentation, process control, traceability, analytical readiness, and manufacturing requirements become more demanding. Groupe PARIMA adapts its support to the maturity of the program, so teams have the expert knowledge and execution needed for each stage.

Stage transitions require process development improvements and operational complexity. Groupe PARIMA supports continuity across development, analytical, manufacturing, and packaging activities, helping teams move forward with better alignment.

As early as possible. Early CDMO involvement reduces technical risk, avoids costly rework, and helps control timelines and costs before key decisions are made. Groupe PARIMA supports multi-stage planning for scale‑up, analytical strategy, and manufacturing readiness, ensuring development choices remain aligned with later‑stage and commercial requirements.

Pharmaceutical companies should prioritize technical fit, dosage form experience, quality systems, and scalability when selecting a CDMO for multi‑stage support. Groupe PARIMA supports multiple project stages at a single site, specializing in liquid, suspension, and semi‑solid dosage forms through a flexible, client‑driven approach.